Introduction
============

Pregnancy is a hypercoagulable state due to an addition in coagulation factors, a reduction in anticoagulants and a deficiency in fibrinolysis ([@B1]). Recurrent miscarriage (RM) is an important clinical problem with many etiologies such as genetic, anatomic, endocrine, and infectious diseases as well as immune defects. Further-more, pregnancy complications such as RM and recurrent implantation failure have been found to be related to thrombophilic gene mutations ([@B2]--[@B7]). RM is defined as the loss of two or more successive pregnancies before 20th week of gestation and affects ∼1% of couples ([@B8]).

Methylenetetrahydrofolate reductase (MTHFR) is an essential enzyme to the folic acid pathway. In this regard, insufficiencies of folic acid or defects in MTHFR have demonstrated DNA hypomethylation and abnormal biochemical and/or phenotypic changes in animal models ([@B9], [@B10]), cell culture ([@B11], [@B12]) and humans ([@B12]--[@B16]). The gene encoding MTHFR has been mapped to the chromosomal region 1p36.3. MTHFR is involved in the synthesis of 5-methylenetetrahydrofolate, which is a cofactor in the enzymatic formation of methionine from homocysteine; and therefore plays a critical role in early embryonic development.

The MTHFR C677T polymorphism results in an amino acid replacement (alanine to valine), which causes the decrease in the activity of the encoded enzyme at 37°*C* or more ([@B17]). In the MTHFR A1298C allele, a polymorphism in exon 7 results in an amino acid replacement (glutamate to alanine). The activity of the encoded enzyme is decreased, although less than that in C677T allele ([@B18]). Most studies show the association of these two polymorphisms with RM in women ([@B6], [@B19]--[@B21]). However, in couples suffering from RM, the role of MTHFR gene polymorphisms in the male partner has not been well defined. The prevalence of the MTHFR mutation in combination with other thrombophilia mutations in RM couples in comparison with controls has been reported ([@B22], [@B23]). However, these studies reported no significant difference in the prevalence of inherited thrombophilia between the two groups.

The aim of this study was to analyze the frequencies of MTHFR C677T and A1298C polymorphisms in male partners of RM couples whose female partners suffered from extensive mutations in MTHFR, compared to those in control couples.

Methods
=======

Patients and controls:
----------------------

Two hundred and twenty five couples with at least three successive pregnancy losses below 20th week of gestation, who were referred to Avicenna Fertility Center, Tehran, Iran, were selected as the case group. All females in the case group were carrying either double heterozygotic polymorphisms of MTHFR C677T and MTHFR A1298C or had at least a homozygotic polymorphism at either MTHFR gene loci (these conditions are termed "MTHFR high risk" in this study).

The control group included 100 couples with at least two live births and no history of pregnancy complications such as miscarriage, stillbirth, small for gestational age fetuses or pre-eclampsia. The exclusion criteria for the case group included anatomic disorders, infectious diseases, single heterozygotic or normal genotype of MTHFR gene at positions 677 and 1298.

The mean age of the different gender groups were 32.4±6.0 and 35.2±4.5 years in females and 37.5±8.4 and 39.8±7.9 years in males, in case and control groups, respectively. The average miscarriage rate of the case group was 3.6±1.5. All couples entered in the study after signing informed written consent and the study was also approved by the ethical committee of Avicenna Research Institute.

DNA extraction and PCR-RFLP analysis:
-------------------------------------

Five milliliters of venous blood were collected from each individual (both men and women) in tubes containing EDTA, and DNA was extracted from the samples using salting out method. Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) amplifications of the DNA samples for MTHFR C677T and A1298C genes were performed using 5′-TGAAGGAGAA GGTGTCTGCGGGA-3′ and 5′-CAAGGAGGAG CTGCTGAAGA-3′ as forward and 5′-AGGACG GTGCGGTGAGAGTG-3′ and 5′-CCACTCCAG CATCACTCACT-3′ as reverse specific primers, respectively ([@B24]). The amplification products were analyzed on 1.5% ethidium bromide-stained agarose gels and then subjected to enzymatic digestion using Hinf I and Mbo II restriction enzymes for MTHFR C677T and A1298C SNPs, respectively.

Statistical analysis:
---------------------

The genotype distributions of each SNP between the case and the control groups were compared by Mann-Whitney U-test. Heterozygous and homozygous mutations of MTHFR C677T and A1298C and also distribution of them were compared between the case and the control groups using Chi-square test. Statistical analysis software program SPSS-13.0 was used for data analysis. The p\<0.05 were considered statistically significant.

Results
=======

MTHFR C677T and A1298C genotype analysis:
-----------------------------------------

PCR-RFLP was carried to analyze the MTHFR genotype composition of the male partners of RM couples whose females were suffering from "MTHFR high risk". To achieve this goal, 225 RM women with "MTHFR high risk" SNPs were selected and their male partners were genotyped for MTHFR A1298C and C677T SNPs. The results were compared with genotype frequency of males in 100 control couples. Genotype distributions in the maternal and paternal control groups of MTHFR C677T polymorphism and also maternal control group of A1298C polymorphism were in Hardy-Weinberg equilibrium (p\>0.05). Paternal control group of A1298C polymorphism was in borderline. The numbers and frequencies of MTHFR C677T and A1298C SNPs in males and females of the case and control groups are shown in [table 1](#T1){ref-type="table"}. The individuals in both groups were further categorized based on gender, RM/Normal and the type of MTHFR SNPs. [Table 1](#T1){ref-type="table"} shows the combinations of the two polymorphisms in both groups. Combined heterozygosity of the two polymorphisms in the males of the two groups is presented as a common phenomenon, 52 (23.1%) and 14 (14%) of males in RM and control groups, respectively. Rare combinations of A1298C/C677T SNPs including homo/hetero-zygote or hetero/ homo-zygote variants were observed in males and females of the both groups ([Table 1](#T1){ref-type="table"}). A major observation of this study was the absence of combined homozygosity for both SNPs in all studied groups/genders. The pattern of individual grouping in [table 1](#T1){ref-type="table"} allowed us to further group them into MTHFR high risk and low risk groups. The data was summarized in [table 2](#T2){ref-type="table"} where the males were statistically compared depending on their degree of RM risk. Surprisingly, a statistically significant difference in the frequency of MTHFR high risk group among the male partners in the RM group was detected compared to that in the normal males (p=0.019).

###### 

Combination of MTHFR A1298C and C677T SNPs in RM and normal groups

  **Group**             **A1298C SNP**   **C677T SNP**                          **Total n (%)**                                     
  --------------------- ---------------- -------------------------------------- -------------------------------------- ------------ -----------
  **RM (n: 225)**                                                                                                                   
  Maternal              AA               0                                      0                                      47           47 (20.8)
  AC                    0                114                                    2 ^[\*](#TFN1){ref-type="table-fn"}^   116 (51.6)   
  CC                    62               0                                      0                                      62 (27.6)    
  Paternal              AA               28                                     46                                     14           88 (39.2)
  AC                    55               52                                     2 ^[\*](#TFN1){ref-type="table-fn"}^   109 (48.4)   
  CC                    27               1 ^[\*](#TFN1){ref-type="table-fn"}^   0                                      28 (12.4)    
  **Normal (n: 100)**                                                                                                               
  Maternal              AA               36                                     19                                     4            59 (59)
  AC                    26               6                                      0                                      32 (32)      
  CC                    8                1 ^[\*](#TFN1){ref-type="table-fn"}^   0                                      9 (9)        
  Paternal              AA               25                                     28                                     3            56 (56)
  AC                    18               14                                     0                                      32 (32)      
  CC                    9                3 ^[\*](#TFN1){ref-type="table-fn"}^   0                                      12 (12)      

Rare combination of A1298C and C677T SNPs including homo/hetero- or hetero/homo -zygotes; RM: recurrent miscarriage

###### 

Frequency of individuals with high and low risk MTHFR genotypes in different groups

                     **Female**   **Male [\*](#TFN2){ref-type="table-fn"}**               
  ------------------ ------------ ------------------------------------------- ----------- ------------
  **RM n (%)**       225 (100)    0 (0)                                       96 (42.7)   129 (57.3)
  **Normal n (%)**   19 (19)      81 (81)                                     29 (29)     71 (71)

P=0.019, Males in MTHFR high and low risk groups were compared using Chi-square test; High risk: Individuals who carried either combined heterozygous C677T/A1298C MTHFR SNPs or at least one homozygous SNP; Low risk: Individuals who carried no C677T/A1298C MTHFR SNPs or had just one heterozygous SNP; RM: recurrent miscarriage

Discussion
==========

This study was aimed to survey the possible role for paternal MTHFR SNPs in RM. In this regard, MTHFR C677T and A1298C SNPs in male partners of RM couples whose female partners had MTHFR high risk genotypes were compared to that in normal counterparts. The results suggest that RM male MTHFR genotypes could also be involved in the pregnancy outcome.

Few studies on MTHFR polymorphism variants and RM have been performed in both male and female partners. In this regard, Jivaraj et al. studied factor V Leiden, MTHFR C677T and prothrombin G20210A SNPs in males and females of RM couples and compared their results with those in normal male and female counterparts ([@B22]). They concluded that multiple genetic thrombophilic mutations, but not single mutations, in either partner, significantly increased the risk of miscarriage ([@B22]). In a similar study, Toth et al. reported no association between paternal thrombophilia and RM ([@B23]). In the study performed by Yenicesu et al., 12 thrombophilic gene polymorphisms including MTHFR C677T and A1298C in RM and normal couples were considered ([@B5]). They reported significantly higher frequency of MTHFR C677T homozygous mutations in RM males ([@B5]).

Role of male MTHFR in RM has also been addressed through the analysis of MTHFR gene promoter hypermethylation, where Rotondo et al. elegantly showed the significant increase in the promoter hypermethylation in RM males ([@B25]). This is in line with the fact that hypermethylation of gene promoters can suppress the transcription process leading to silencing of gene expression ([@B26]). Lack of MTHFR activity due to presence of its polymorphic variants will reduce the availability of methyl group donors that are needed for methylalation of DNA ([@B9]) which may adversely affect the global genome methylation and also the genomic imprinting of paternal genes in spermatogenetic cells. On the other hand, genomic imprinting which is involved in silencing of genes at the level of imprinted loci is highly regulated by DNA methylation ([@B27]). In this regard, impaired methylation imprints have been shown to lead to generation of poorly developed placenta that carried trophoblasts with proliferation, apoptosis and differentiation abnormalities ([@B28]--[@B31]). These data suggest that a global hypomethylation of sperm DNA following hypermethylation of MTHFR promoter can cause pregnancy loss through male factor in RM couples ([@B25]). Such an effect of MTHFR polymorphism may also account for repeated implantation failure in infertile couples undergoing *in vitro* fertilization treatments.

Considering the nature of our study, significantly increased MTHFR SNPs were found in RM males compared to that in males of normal couples. This will increase the Mendelian risk for the embryo to gain polymorphic MTHFR variants. Interestingly, no combined homozygosity for C677T and A1298C SNPs was found among the individuals in this study and thus our data cannot exclude the possibility that inheritance of such combination might predispose the product of conception to embryonic/fetal death.

It is also well documented that DNA hypermethylation directly affects chromosomal instability ([@B32]). It is thus suggested that folate deficiency and DNA hypomethylation following increased frequency of MTHFR polymorphisms may be associated with chromosomal instability ([@B33]) which may lead to production of aneuploid gametes and embryos. Chromosomal aneuploidies are well known causes of first trimester miscarriage ([@B34]).

Conclusion
==========

Previous reports ([@B6], [@B19], [@B35]) as well as the data presented in this study are in favor of an increased number of MTHFR polymorphic variants donated by both male and female partners of RM couples to the embryo. The MTHFR gene composition of the embryo may thus be adversely affected by DNA hypomethylation that may increase the risk of embryonic/fetal death and be reflected as recurrent pregnancy loss in the couples. In this regard, MTHFR genotyping of couples with multiple pregnancy losses or repeated implantation failures who remain unresponsive to treatments, followed by selection of IVF embryos with the least frequencies of MTHFR polymorphic variants by preimplantation genetic diagnosis (PGD) may play a significant role in increasing the survival chance of embryo/fetus.
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